Title of Activity: DNP Challenging Cases In Dermatology Plaque Psoriasis -Volume 1/Broadcast #5

Faculty:
Leigh Ann Pansch, MSN, FNP-BC, DCNP
Margaret Bobonich, DNP, FNP-BC, DCNP

Release Date: 5/8/2023
Expiration Date: 5/8/2024

Target Audience:
This activity has been designed to meet the educational needs of nurses, nurse practitioners, and physician assistants. Other healthcare providers may also participate.

CREDIT INFORMATION
Estimated time for completion: 60 minutes
THERE IS NO FEE FOR THIS ACTIVITY
This activity is awarded 1.00 Nursing Continuing Professional Development/Continuing Education (NCPD/CE) Credits, which includes 0.25 ANCC Pharmacology Credits

To Receive Credit:
1. Watch the broadcast in its entirety - CLICK HERE
2. Complete post test and achieve a passing score of 70% or higher.
3. Complete/submit the evaluation.
4. Print out your certificate, as well as save it to your computer.

ACCREDITATION STATEMENT:
The Dermatology Nurses’ Association (DNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

This educational activity is jointly provided by Dermatology Nurses’ Association and Excalibur Medical Education.

PROGRAM OVERVIEW
Program Purpose: The purpose of this activity is to cover the information that clinicians need to know to formulate effective, individualized treatment plans for their patients with psoriasis. The program contains a pediatric case study with an overview of the treatments available, including their benefits and drawbacks, so that dermatology specialists can provide psoriasis care that maximizes their patients’ chances of skin clearance, and delivers the health and quality-of-life benefits that result from optimal management of this challenging condition.

Learning Objectives
Upon successful completion of this educational program, the participant should be able to:
· Describe the procedure that should be followed to assess body surface coverage area among patients with plaque psoriasis.
· Determine appropriate parameters of treatment success for patients with plaque psoriasis.
· Discuss the safety and efficacy of biologic therapies commonly used for the treatment of plaque psoriasis.

DISCLOSURE
It is the policy of DNA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by DNA prior to accreditation of the activity.

Planning committee members:
Linda Markham, BSN, RN, DNC, Executive Director & Program Director, Dermatology Nurses’ Association
Scott Kober, MBA, Managing Director, Excalibur Medical Education
Kristin Harper, PhD, MPH, ELS, Medical Writer
Leigh Ann Pansch, MSN, FNP-BC, DCNP
Margaret Bobonich, DNP, FNP-C, FAANP
Katherine Leigh, DNP, APRN, FNP-C, Nurse Planner
Lynn Smith, DNP, NP-C, FNP-C Content Expert
Trudy Adamson, RN, MSN, DNC, AP-PD
have disclosed that they have no relevant financial relationships or conflicts of interest with ineligible companies related directly or indirectly to this educational activity.

Faculty:
Leigh Ann Pansch, MSN, FNP-BC, DCNP and Margaret Bobonich, DNP, FNP-C, FAANP
have disclosed that they have no relevant financial relationships or conflicts of interest with ineligible companies related directly or indirectly to this educational activity.

All of the relevant financial relationships listed for these individuals have been mitigated.

COMMERCIAL SUPPORT
Support for this activity has been made possible through educational grants from Janssen and Amgen.

Margaret Bobonich DNP, FNP, DCNP, FAANP

Dermatology Nurse Practitioner, Center for Dermatology Nursing Practice

Appearances